Multiple head and neck tumors frequently originate from a single preneoplastic lesion

American Journal of Pathology

Volumn 161, Issue 3, 2002, Pages 1051-1060

  Tabor, Maarten P ^a   Brakenhoff, Ruud H ^a   Ruijter Schippers, Henrique J ^a   Van der Wal, Jacqueline E ^a   Snow, Gordon B ^a   Leemans, C René ^a   Braakhuis, Boudewijn J M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOMAL LOCALIZATION; CLINICAL ARTICLE; CLONOGENESIS; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE MUTATION; HEAD AND NECK CANCER; HUMAN; MALE; MULTIPLE CANCER; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0036733655     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64266-6     Document Type: Article

References (33)

1. Upper aerodigestive tract cancers
2. Head and neck cancer
3. Second malignant tumors in head and neck squamous cell carcinoma: The overshadowing threat for patients with early-stage disease
4. Multiple primary cancer in patients with cancer of the head and neck: Second cancer of the head and neck, esophagus, and lung
5. Genetic progression model for head and neck cancer: Implications for field cancerization
6. Location of candidate tumour suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas
7. Persistence of genetically altered fields in head and neck cancer patients: Biological and clinical implications
8. Field cancerisation and polyclonal p53 mutation in the upper aerodigestive tract
9. Discordance of genetic alterations between primary head and neck tumors and corresponding metastases is associated with mutational status of the TP53 gene
10. Field cancerization in oral stratified squamous epithelium
11. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract
12. The origins of multiple squamous cell carcinomas in the aerodigestive tract
13. Common clonal origin of synchronous primary head and neck squamous cell carcinomas: Analysis by tumor karyotypes and fluorescence in situ hybridization
14. Multiple head and neck tumors: Evidence for a common clonal origin
15. Synchronous oral carcinomas: Independent or common clonal origin?
16. Second esophageal tumors in patients with head and neck squamous cell carcinoma: An assessment of clonal relationships
17. Multiple oral squamous epithelial lesions: Are they genetically related?
18. Multiple primary malignant tumors. A survey of the literature and a statistical study
19. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck
20. Multiple regions of deletion on chromosome arm 13q in head-and-neck squamous-cell carcinoma
21. Molecular assays for the diagnosis of minimal residual head-and-neck cancer: Methods, reliability, pitfalls, and solutions
22. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma
23. Identification of p53 gene mutations in bladder cancers and urine samples
24. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment
25. Molecular support for field cancerization in the head and neck
26. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia
27. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial
28. Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma
29. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx
30. Evolutionary conservation and somatic mutation hotspot maps of p53: Correlation with p53 protein structural and functional features
31. Second primary tumors and field cancerization in oral and oropharyngeal cancer: Molecular techniques provide new insights and definitions